Adults with diabetes using an automated insulin delivery system had minimal change in time in range after switching ...
(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today provided a ...
Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...
Young and the Invested on MSN
Growth stocks are hurting, but Wall Street still loves these 7 picks
This article discusses the best growth stocks to buy right now.
Abbott (NYSE:ABT) today said it launched a new bundle with Withings for its Lingo over-the-counter glucose biosensor.
CES offered a glimpse into the future of health tech, including a tracker for perimenopause symptoms, an adorable robotic dog for dementia sufferers, and a robotic exoskeleton that assists walking.
Glucotrack (Nasdaq:GCTK) today provided an update on the planned regulatory timeline for its continuous blood glucose monitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results